| Literature DB >> 31428338 |
Ji-Hye Jung1, Su-Ji Kim1, Jae Yong Lee1, So-Ra Yoon1, Su-Yeon You1, Sung Hyun Kim1.
Abstract
This study aimed to evaluate the safety (hemolysis and enzyme activity), probiotic properties (gastrointestinal tract tolerance, adhesion, hydrophobicity, and auto-aggregation), and functional characteristics (antimicrobial, antioxidant, and β-galactosidase activities) of lactic acid bacteria (LAB), isolated from kimchi, in order to select a multifunctional LAB strain for starter culture in fermented food. The five isolated strains included Lactobacillus plantarum WiKim83, L. plantarum WiKim84, Pediococcus pentosaceus WiKim85, P. pentosaceus WiKim86, and L. plantarum WiKim87, as identified by 16S rRNA gene sequence analysis; they were confirmed to be nonhemolytic and not able to produce β-glucuronidase, a carcinogenic enzyme. Probiotic properties of the five LAB strains were evaluated relative to those of commercial Lactobacillus rhamnosus GG, and results revealed probiotic potential of three strains (L. plantarum WiKim83, L. plantarum WiKim84, and L. plantarum WiKim87) to be superior. L. plantarum WiKim84 showed high antimicrobial activity against pathogens, and L. plantarum WiKim83 exhibited the highest antioxidant and β-galactosidase activities. Based on the probiotic and functional properties, the main characteristics of each strain were highlighted and two of them, L. plantarum WiKim83 and L. plantarum WiKim87, were selected as the most potent by principal component analysis. These strains showed antimicrobial, β-galactosidase, and antioxidant activities, which recommend their suitability as starter culture in various fermented foods.Entities:
Keywords: Lactobacillus plantarum; antimicrobial activity; antioxidant activity; probiotic; β‐galactosidase activity
Year: 2019 PMID: 31428338 PMCID: PMC6694436 DOI: 10.1002/fsn3.1075
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 2.863
Molecular identification of selected lactic acid bacteria strains by 16S rRNA gene sequencing
| Strain | Molecular identification | Similarity (%) | Accession number |
|---|---|---|---|
| WiKim83 |
| 99.9 |
|
| WiKim84 |
| 99.9 |
|
| WiKim85 |
| 99.9 |
|
| WiKim86 |
| 99.9 |
|
| WiKim87 |
| 99.9 |
|
GenBank database.
Hemolysis and enzyme production by the isolated lactic acid bacteria strains
|
|
|
|
|
| |
|---|---|---|---|---|---|
| Hemolysis |
|
|
|
|
|
| Enzyme | |||||
| Control | 0 | 0 | 0 | 0 | 0 |
| Alkaline phosphatase | 0 | 0 | 0 | 10 | 0 |
| Esterase | 0 | 0 | 0 | 5 | 0 |
| Esterase lipase | 0 | 0 | 0 | 5 | 0 |
| Lipase | 0 | 0 | 0 | 10 | 0 |
| Leucine arylamidase | 20 | 20 | ≥40 | ≥40 | 30 |
| Valine arylamidase | 0 | 0 | 20 | 30 | 20 |
| Cystine arylamidase | 0 | 0 | 0 | 10 | 0 |
| Trypsin | 0 | 0 | 0 | 10 | 0 |
| α‐Chymotrypsin | 0 | 0 | 0 | 0 | 0 |
| Acid phosphatase | 0 | 0 | 0 | 30 | 0 |
| Naphthol‐AS‐BI‐phosphohydrolase | 0 | 0 | 20 | 30 | 0 |
| α‐Galactosidase | 0 | 0 | 0 | 20 | 0 |
| β‐Galactosidase | 20 | 20 | 20 | 30 | ≥40 |
| β‐Glucuronidase | 0 | 0 | 0 | 0 | 0 |
| α‐Glucosidase | 20 | 20 | 0 | 10 | 20 |
| β‐Glucosidase | 20 | 20 | 20 | 20 | 20 |
| N‐Acetyl‐β‐glucosaminidase | 20 | 20 | 30 | 5 | 30 |
| α‐Mannosidase | 0 | 0 | 0 | 0 | 0 |
| α‐Fucosidase | 0 | 0 | 0 | 0 | 0 |
Amount of enzymes derived from isolated LAB strains according to the API ZYM kit. All values are in nmol.
In vitro probiotic properties of isolated lactic acid bacteria strains
| Strains | Gastrointestinal tract tolerance (log CFU/ml) | Adhesion (%) | Hydrophobicity (%) | Auto‐aggregation (%) | |||
|---|---|---|---|---|---|---|---|
| Initial | Acid | Gastric juice | Bile salt | ||||
|
| 9.15 ± 0.05 | 9.16 ± 0.06a | 8.93 ± 0.26a | 9.20 ± 0.15a | 77.33 ± 2.08a | 50.61 ± 0.76a | 93.28 ± 0.01a |
|
| 9.17 ± 0.06 | 8.27 ± 0.11b | 8.06 ± 0.32b | 9.15 ± 0.60a | 71.00 ± 2.00bc | 37.70 ± 0.42c | 90.50 ± 4.75a |
|
| 9.14 ± 0.07 | 6.01 ± 0.43c | 5.49 ± 0.32c | 6.75 ± 0.14b | 54.67 ± 3.51d | 11.76 ± 2.11d | 93.39 ± 0.25a |
|
| 9.22 ± 0.98 | 5.63 ± 0.21c | 5.35 ± 0.13c | 5.84 ± 0.35c | 49.33 ± 2.08e | 48.22 ± 1.27ab | 85.04 ± 0.08b |
|
| 9.13 ± 0.06 | 9.16 ± 0.04a | 8.98 ± 0.07a | 9.20 ± 0.52a | 73.05 ± 1.53ab | 44.65 ± 1.52b | 91.48 ± 0.72a |
|
| 9.14 ± 0.35 | 8.26 ± 0.08b | 7.98 ± 0.21b | 9.02 ± 0.10a | 69.25 ± 2.45c | 50.70 ± 5.20a | 92.00 ± 1.42a |
Data are mean ± SD (n = 3). Mean values with different superscript letters (a–e) in the same column are significantly different, based on Duncan's multiple‐range test (p < 0.05).
Antimicrobial activity of isolated lactic acid bacteria strains against foodborne pathogens
| Indicator microorganism | Inhibition zone (mm) | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
| Gentamicin (30 μg/ml) | |
| Gram (+) | ||||||
|
| 16.76 ± 0.20b | 17.43 ± 0.21a | 15.73 ± 0.16c | 16.02 ± 0.25e | 13.94 ± 0.17c | 15.09 ± 0.31d |
|
| 14.70 ± 0.28 b | 16.36 ± 0.11a | 13.98 ± 0.06c | 11.91 ± 0.13e | 12.45 ± 0.24d | 7.18 ± 0.01f |
|
| 8.83 ± 0.21d | 10.45 ± 0.35b | 8.49 ± 0.25e | 7.22 ± 0.06f | 9.57 ± 0.15c | 13.23 ± 0.18a |
|
| 12.52 ± 0.49b | 11.59 ± 0.78c | 10.92 ± 0.86d | 9.58 ± 0.19e | 12.92 ± 0.06a | n.d. |
| Gram (−) | ||||||
|
| 14.00 ± 0.11b | 16.53 ± 0.13a | 13.35 ± 0.10c | 11.51 ± 0.16d | 14.16 ± 0.17b | 7.87 ± 0.22e |
|
| 13.22 ± 0.28b | 14.10 ± 0.37a | 13.90 ± 0.11a | 12.75 ± 0.10c | 13.43 ± 0.27b | 9.68 ± 0.04d |
|
| 13.96 ± 0.60a | 13.69 ± 0.17ab | 13.57 ± 0.70ab | 12.62 ± 0.36bc | 13.32 ± 0.82ab | 12.25 ± 0.53c |
|
| 10.43 ± 0.08 | 10.47 ± 0.19 | n.d. | n.d. | 10.64 ± 0.39 | 10.49 ± 0.04 |
|
| 12.91 ± 0.18b | 13.00 ± 0.13b | 12.66 ± 0.18b | 12.13 ± 0.16b | 13.02 ± 0.14b | 18.54 ± 1.41a |
|
| 15.17 ± 0.23a | 15.27 ± 0.20a | 14.36 ± 0.13b | 13.79 ± 0.40c | 15.53 ± 0.17a | 13.10 ± 0.45d |
Data are mean ± SD (n = 3). Mean values with different superscript letters (a–f) in the same row are significantly different, based on Duncan's multiple‐range test (p < 0.05).
n.d., not detected (inhibition zones with values ≤7 mm were assumed to be devoid of antimicrobial activity).
Antioxidant activity of the culture supernatants from isolated lactic acid bacteria strains
| Antioxidant activity (%) | ||||||
|---|---|---|---|---|---|---|
|
|
|
|
|
| Ascorbic acid (1 mg/ml) | |
| DPPH+ | 35.35 ± 3.98b | 34.05 ± 1.70b | 32.19 ± 1.14bc | 29.33 ± 1.60c | 34.46 ± 0.92b | 99.99 ± 0.10a |
| ABTS•+ | 99.05 ± 0.90ab | 98.90 ± 0.10ab | 98.85 ± 0.28b | 97.69 ± 0.60c | 97.41 ± 0.94c | 99.99 ± 0.01a |
|
| 38.27 ± 1.10b | 33.37 ± 0.93cd | 31.23 ± 1.07d | 24.32 ± 0.99e | 35.36 ± 1.62c | 93.33 ± 0.49a |
Data are mean ± SD (n = 3). Means with different superscript letters (a–e) in the same row are significantly different, based on Duncan's multiple‐range test (p < 0.05).
Figure 1β‐Galactosidase activity of isolated lactic acid bacteria strains. The activities are expressed in Miller units. Error bars indicate the SD of three independent experiments. Means in each column, having a common letter, are significantly different from the others (p < 0.05)
Figure 2Principal component analysis (PCA) biplot based on the probiotic properties of isolated lactic acid bacteria strains. PCA results show that 81.26% of the total variation was distributed in PC1 (51.35%) and PC2 (29.91%)